Cardinal Health (NYSE: CAH) reported Q2 EPS of $1.74, $0.30 better than the analyst estimate of $1.44. Revenue for the quarter came in at $41.5 billion versus the consensus estimate of $41.44 billion.

GUIDANCE:

Cardinal Health sees FY2021 EPS of $5.85-$6.10, versus the consensus of $5.88.

• Cardinal Health raised its fiscal year 2021 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $5.85 to $6.10, from the prior range of $5.65 to $5.95.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.